Fundz

Montréal healthtech startup Epitopea raised $31M USD ($43M CAD) in pre-Series A funding led by Investissement Québec to develop RNA-based cancer immunotherapies.

PRIVATEOct 25, 2024

Amount Raised

$31 Million

Round Type

Pre-Series A

Biotechnology

Investors

Investissement QuébecNovateur VenturesadMare BioInnovationsIRICoRCambridge Innovation CapitalCTI Life SciencesAdvent Life SciencesFonds De Solidarité FtqJonathan MilnerHarrington Discovery Institute

Description

Epitopea has successfully raised $31 million USD in pre-Series A funding to support the development of their RNA-based cancer immunotherapies. The financing will focus on clinical development and pre-clinical research aiming to advance targeted treatments for hard-to-treat tumors.

Quick answer

Epitopea raised $31 Million in a Pre-Series A round, dated October 25, 2024. Investors: Investissement Québec, Novateur Ventures, adMare BioInnovations, IRICoR, Cambridge Innovation Capital, CTI Life Sciences, Advent Life Sciences and Fonds De Solidarité Ftq.

How much did Epitopea raise?
Epitopea raised $31 Million in a Pre-Series A round on October 25, 2024.
Who invested in Epitopea?
Investissement Québec, Novateur Ventures, adMare BioInnovations, IRICoR, Cambridge Innovation Capital, CTI Life Sciences, Advent Life Sciences and Fonds De Solidarité Ftq are named as investors in this round.
What does Epitopea do?
Epitopea is a transatlantic biotechnology company developing transformational immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication.
Who are the decision-makers at Epitopea?
Fundz holds 1 contact at Epitopea. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Epitopea that raised within 45 days of this round, from Fundz verified event records.

  • Qi Biodesign raised $75M (Series A) on December 9, 2024.
  • Senti Biosciences raised $38M on December 9, 2024.
  • Abselion raised $8.4M (Series A) on December 9, 2024.
  • Citryll raised $89M (Series B) on December 9, 2024.
  • Canton Strategic Holdings, Inc. raised $2M (Seed) on December 9, 2024.
  • Mythic Therapeutics raised $30M on December 9, 2024.

Who to call at Epitopea, and when

A new round usually means Epitopea is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Epitopea raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Epitopea, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Epitopea. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Epitopea

About

Epitopea is a transatlantic biotechnology company developing transformational immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Epitopea raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Epitopea's next move

See what Strategic adds

Epitopea raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.